There are not enough studies to determine whether it is safe for pregnancy, so avoid it to be safe (x)
Start your intake Understanding How Semaglutide Works for Weight Loss Semaglutide activates GLP-1 receptors in your brain, stomach, and pancreas to trigger three key weight-loss mechanisms
Research has demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles
#Pharmacy #DrugSafety #CDSCO #PatientSafety #Pharmacovigilance #EvidenceBasedMedicine #Healthcare #RegulatoryAffairs #FixedDoseCombination #PublicHealth #PharmaProfessionals To view or add a comment, sign in Regulatory Update: Ban on Fixed-Dose Combination (FDC) Medicines in India The Ministry of Health & Family Welfare, Government of India, in coordination with the Central Drugs Standard Control Organisation (CDSCO), has prohibited 16 Fixed-Dose Combination (FDC) medicines with immediate effect (June 2026)
Rapid weight loss, with or without GLP-1s, will result in rebound
Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147
